Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00700596 · ClinicalTrials.gov registry record · Early Phase 1
Effects of Salvinorin A in Healthy Controls
A Early Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 105
- Enrollment target
NCT00700596: Completed Early Phase 1 study, sponsored by Yale University.
NCT00700596 is a Early Phase 1 study that has completed, run by Yale University. The registered enrollment target is 105 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (98% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00700596, a Early Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 105 participants
- Enrollment target
Study Summary
This study evaluates the effects of Salvinorin A (SA). SA is the active ingredient of the plant Salvia divinorum that is known to have been used by Mexican Indians as part of religious rituals. The purpose of this project is to understand what people experience when they consume Salvinorin A.
Interventions
- DRUG Placebo
- DRUG Salvinorin A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2009-02-12 |
| Est. Completion | 2014-08-22 |
| Phase | Early Phase 1 |
What the finished NCT00700596 record still lists
NCT00700596 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (98% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00700596 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00700596 about?
NCT00700596 is a clinical study titled "Effects of Salvinorin A in Healthy Controls". This study evaluates the effects of Salvinorin A (SA). SA is the active ingredient of the plant Salvia divinorum that is known to have been used by Mexican Indians as part of religious rituals. The purpose of this project is to understand what people experience when they consume Salvinorin A.
What is the current status of trial NCT00700596?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 105 participants. The study started on 2009-02-12. Estimated completion is 2014-08-22.
What interventions are being tested in trial NCT00700596?
The interventions under investigation include: Placebo (DRUG), Salvinorin A (DRUG).
Who is sponsoring clinical trial NCT00700596?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00700596's enrollment target sits among peer trials
105 175th of 2000 higher than 1,825 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI